8-Methyl-3-methyl­sulfanyl-8a,8b-di­hydro-5H-1-oxa-2,4-di­aza­ace­naphthyl­ene

In the tricyclic title compound, C(11)H(12)N(2)OS, the 2,3,4,5-tetra­hydro­pyridine ring adopts a half-chair conformation. This ring makes dihedral angles of 27.72 (7) and 45.17 (7)°, respectively, with the isoxazole and the cyclo­hexa-1,3-diene rings while the isoxazole ring is oriented at an acute...

Descripción completa

Detalles Bibliográficos
Autores principales: Abou, Akoun, Bamba, Fanté, Marrot, Jérôme, Yaya, Soro, Coustard, Jean-Marie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Union of Crystallography 2021
Materias:
Data Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9462342/
https://www.ncbi.nlm.nih.gov/pubmed/36337322
http://dx.doi.org/10.1107/S241431462100674X
Descripción
Sumario:In the tricyclic title compound, C(11)H(12)N(2)OS, the 2,3,4,5-tetra­hydro­pyridine ring adopts a half-chair conformation. This ring makes dihedral angles of 27.72 (7) and 45.17 (7)°, respectively, with the isoxazole and the cyclo­hexa-1,3-diene rings while the isoxazole ring is oriented at an acute angle of 63.46 (7)° with respect to the cyclo­hexa-1,3-diene ring. In the crystal, mol­ecules associate via C—H⋯N hydrogen bonds and C—H⋯π inter­actions, forming a three-dimensional network. [Image: see text]

Ejemplares similares